ArticleInternational journal of clinical oncology2022

Response to first-line chemotherapy regimen is associated with efficacy of ımmune checkpoint blockade therapies in patients with metastatic urothelial carcinoma.

Deniz Tural et al.PubMed ↗Publisher ↗

No numbers read from the abstract.